Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-037147

Chief Scientific Officer bought 5,000 shares at an average $6.22 ($31,097)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MacBeath Gavin Chief Scientific Officer 2021-09-20 Purchase +4,943 $6.22 $30,744 49,710 D
MacBeath Gavin Chief Scientific Officer 2021-09-21 Purchase +57 $6.19 $353 49,767 D
Open-market purchases · 5,000 sh · avg $6.22 · $31,097
Loading xslF345X03/doc4.xml…